Download PDF
J Reconstr Microsurg
DOI: 10.1055/a-2383-4617
Original Article

Flap-Based Reconstruction in Patients with Autoimmune Disease: An Institutional Experience with the Deep Inferior Epigastric Perforator Flap and Review of the Literature

Artur Manasyan
1   Keck School of Medicine, University of Southern California, Los Angeles, California
,
Eloise W. Stanton 
2   Division of Plastic and Reconstructive Surgery, Keck School of Medicine, Los Angeles, California
,
Tayla Moshal
2   Division of Plastic and Reconstructive Surgery, Keck School of Medicine, Los Angeles, California
,
David A. Daar
2   Division of Plastic and Reconstructive Surgery, Keck School of Medicine, Los Angeles, California
,
Joseph N. Carey
2   Division of Plastic and Reconstructive Surgery, Keck School of Medicine, Los Angeles, California
,
Emma Koesters
2   Division of Plastic and Reconstructive Surgery, Keck School of Medicine, Los Angeles, California
› Author Affiliations Funding None.
› Further Information
Also available at
    Permissions and Reprints

Abstract

Background Autoimmune diseases are associated with characteristic chronic inflammation, aberrations in tissue perfusion, and hypercoagulability, and thus have considerable implications for local and free-flap reconstruction. We seek to summarize the current evidence on outcomes of flap-based reconstruction in patients with pre-existing autoimmune disease and present our experience with autologous breast reconstruction in this population.

Methods PubMed, Embase, Scopus, Cochrane, and Web of Science were searched for relevant articles, and pertinent data were presented qualitatively. Institutional data were queried for patients who underwent autologous breast reconstruction with deep inferior epigastric perforator (DIEP) flaps between 2015 and 2024. A retrospective review was conducted to identify DIEP patients with a history of autoimmune disease. Data on patient demographics, medication history, flap outcomes, and perioperative complications were collected.

Results The majority of existing studies found no increased independent risk of flap complications. However, other complications, predominantly wound dehiscence, were independently associated with autoimmune disease. Regarding immunosuppressant therapy, the literature demonstrated that perioperative glucocorticoid use was consistently associated with all complications, including seroma, infection, wound disruption, and partial flap loss.

Our 13-patient institutional experience identified no cases of total flap loss or microvascular thrombotic complications. There was one case of partial flap necrosis further complicated by abdominal site cellulitis, and one case of recipient-site dehiscence managed with local wound care. No patients required re-operation for flap or donor-site complications.

Conclusion The literature suggests that flap reconstruction can be performed safely in patients with autoimmune conditions, which was also supported by our institutional experience. While there is likely minimal risk of microsurgical complications in the context of free tissue transfer, donor-site morbidity and wound dehiscence remain major concerns for patients with a history of autoimmune disease. Limiting the use of immunosuppressive agents, especially corticosteroids, may potentially improve outcomes of flap reconstruction.

Keywords

flap - autoimmune - microsurgery - reconstruction


Publication History

Received: 26 April 2024

Accepted: 26 July 2024

Accepted Manuscript online:
12 August 2024

Article published online:
05 September 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Richard-Eaglin A, Smallheer BA. Immunosuppressive/autoimmune disorders. Nurs Clin North Am 2018; 53 (03) 319-334
    CrossrefPubMedSearch in Google Scholar
  • 2 Conrad N, Misra S, Verbakel JY. et al. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet 2023; 401 (10391): 1878-1890
    CrossrefPubMedSearch in Google Scholar
  • 3 Wang L, Wang FS, Gershwin ME. Human autoimmune diseases: a comprehensive update. J Intern Med 2015; 278 (04) 369-395
    CrossrefPubMedSearch in Google Scholar
  • 4 Sanjadi M, Rezvanie Sichanie Z, Totonchi H, Karami J, Rezaei R, Aslani S. Atherosclerosis and autoimmunity: a growing relationship. Int J Rheum Dis 2018; 21 (05) 908-921
    CrossrefPubMedSearch in Google Scholar
  • 5 Jin K, Parreau S, Warrington KJ. et al. Regulatory T cells in autoimmune vasculitis. Front Immunol 2022; 13: 844300
    CrossrefPubMedSearch in Google Scholar
  • 6 Kirloskar KM, Dekker PK, Kiene J. et al. The relationship between autoimmune disease and disease-modifying antirheumatic drugs on wound healing. Adv Wound Care (New Rochelle) 2022; 11 (12) 650-656
    CrossrefPubMedSearch in Google Scholar
  • 7 Avishai E, Yeghiazaryan K, Golubnitschaja O. Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalised medicine. EPMA J 2017; 8 (01) 23-33
    CrossrefPubMedSearch in Google Scholar
  • 8 Silvestri E, Scalera A, Emmi G. et al. Thrombosis in autoimmune diseases: a role for immunosuppressive treatments?. Semin Thromb Hemost 2016; 42 (06) 650-661
    Thieme ConnectPubMedSearch in Google Scholar
  • 9 Sitia S, Atzeni F, Sarzi-Puttini P. et al. Cardiovascular involvement in systemic autoimmune diseases. Autoimmun Rev 2009; 8 (04) 281-286
    CrossrefPubMedSearch in Google Scholar
  • 10 Shanmugam VK, Angra D, Rahimi H, McNish S. Vasculitic and autoimmune wounds. J Vasc Surg Venous Lymphat Disord 2017; 5 (02) 280-292
    CrossrefPubMedSearch in Google Scholar
  • 11 Rozin AP, Egozi D, Ramon Y. et al. Large leg ulcers due to autoimmune diseases. Med Sci Monit 2011; 17 (01) CS1-CS7
    CrossrefPubMedSearch in Google Scholar
  • 12 Egol KA, Jazrawi LM, DeWal H, Su E, Leslie MP, Di Cesare PE. Orthopaedic manifestations of systemic lupus erythematosus. Bull Hosp Jt Dis 2001; 60 (01) 29-34
    PubMedSearch in Google Scholar
  • 13 Li J, Shujaat S, Shaheen E, Politis C, Jacobs R. Autoimmune diseases and orthognathic surgery: a case series of 12 patients. J Plast Reconstr Aesthet Surg 2023; 84: 413-421
    CrossrefPubMedSearch in Google Scholar
  • 14 Lamberty BG, Cormack GC. Progress in flap surgery: greater anatomical understanding and increased sophistication in application. World J Surg 1990; 14 (06) 776-785
    CrossrefPubMedSearch in Google Scholar
  • 15 Fang F, Chung KC. An evolutionary perspective on the history of flap reconstruction in the upper extremity. Hand Clin 2014; 30 (02) 109-122 , v
    CrossrefPubMedSearch in Google Scholar
  • 16 Schaverien MV, Dean RA, Myers JN, Fang L, Largo RD, Yu P. Outcomes of microvascular flap reconstruction of the head and neck in patients receiving systemic immunosuppressive therapy for organ transplantation. J Surg Oncol 2018; 117 (07) 1575-1583
    CrossrefPubMedSearch in Google Scholar
  • 17 Ifarraguerri AM, Gupta P, Quan T. et al. Risks of immunosuppressive therapy in patients undergoing open reduction internal fixation for ankle fractures. J Foot Ankle Surg 2023; 62 (05) 802-806
    CrossrefPubMedSearch in Google Scholar
  • 18 Vasavada K, Jazrawi LM, Samuels J. Perioperative management of immunosuppressive medications in rheumatic disease patients undergoing arthroscopy. Curr Rev Musculoskelet Med 2021; 14 (06) 421-428
    CrossrefPubMedSearch in Google Scholar
  • 19 Gaffo A, Saag KG, Curtis JR. Treatment of rheumatoid arthritis. Am J Health Syst Pharm 2006; 63 (24) 2451-2465
    CrossrefPubMedSearch in Google Scholar
  • 20 Hussain Y, Khan H. Immunosuppressive drugs. Encyclopedia of Infection and Immunity 2022; 726-740
    CrossrefPubMedSearch in Google Scholar
  • 21 Kucur C, Durmus K, Uysal IO. et al. Management of complications and compromised free flaps following major head and neck surgery. Eur Arch Otorhinolaryngol 2016; 273 (01) 209-213
    CrossrefPubMedSearch in Google Scholar
  • 22 Mady LJ, Poonia SK, Baddour K. et al. Consensus of free flap complications: Using a nomenclature paradigm in microvascular head and neck reconstruction. Head Neck 2021; 43 (10) 3032-3041
    CrossrefPubMedSearch in Google Scholar
  • 23 Kim SW. Perforator free flap coverage of chronic lower extremity ulcers in patients with autoimmune diseases under immunosuppression. Int J Low Extrem Wounds 2021; 20 (04) 355-363
    CrossrefPubMedSearch in Google Scholar
  • 24 Koster ITS, Borgdorff MP, Jamaludin FS, de Jong T, Botman M, Driessen C. Strategies following free flap failure in lower extremity trauma: a systematic review. JPRAS Open 2023; 36: 94-104
    CrossrefPubMedSearch in Google Scholar
  • 25 Cleveland EC, Fischer JP, Nelson JA, Wink JD, Levin LS, Kovach III SJ. Free flap lower extremity reconstruction in the obese population: does weight matter?. J Reconstr Microsurg 2014; 30 (04) 263-270
    Thieme ConnectPubMedSearch in Google Scholar
  • 26 Fischer JP, Wink JD, Nelson JA. et al. A retrospective review of outcomes and flap selection in free tissue transfers for complex lower extremity reconstruction. J Reconstr Microsurg 2013; 29 (06) 407-416
    Thieme ConnectPubMedSearch in Google Scholar
  • 27 Wang TY, Serletti JM, Kolasinski S, Low DW, Kovach SJ, Wu LC. A review of 32 free flaps in patients with collagen vascular disorders. Plast Reconstr Surg 2012; 129 (03) 421e-427e
    CrossrefPubMedSearch in Google Scholar
  • 28 Yan M, Rajput S, Singh K. et al. Long-term survival analysis of free flap reconstruction in patients with collagen vascular disorders. J Plast Reconstr Aesthet Surg 2022; 75 (12) 4371-4378
    CrossrefPubMedSearch in Google Scholar
  • 29 Odorico SK, Reuter Muñoz K. J Nicksic P, et al. Surgical and demographic predictors of free flap salvage after takeback: a systematic review. Microsurgery 2023; 43 (01) 78-88
    CrossrefPubMedSearch in Google Scholar
  • 30 Rubio GA, McGee CS, Thaller SR. Autologous breast reconstruction surgery outcomes in patients with autoimmune connective tissue disease. J Plast Reconstr Aesthet Surg 2019; 72 (05) 848-862
    CrossrefPubMedSearch in Google Scholar
  • 31 Shuck J, Patel KM, Franklin B, Fan KL, Hannan L, Nahabedian MY. Impact of connective tissue disease on oncologic breast surgery and reconstruction. Ann Plast Surg 2016; 76 (06) 635-639
    CrossrefPubMedSearch in Google Scholar
  • 32 Chin KY, Chalmers CR, Bryson AV, Weiler-Mithoff EM. Breast reconstruction in the high risk patient with systemic connective tissue disease: a case series. J Plast Reconstr Aesthet Surg 2013; 66 (01) 61-66
    CrossrefPubMedSearch in Google Scholar
  • 33 Arakelyan S, Aydogan E, Spindler N, Langer S, Bota O. A retrospective evaluation of 182 free flaps in extremity reconstruction and review of the literature. GMS Interdiscip Plast Reconstr Surg DGPW 2022; 11: Doc01
    PubMedSearch in Google Scholar
  • 34 Sleiman AG, Vallette N, Milto AJ, Revelt N, Scaife SL, Thuppal SV. The effect of autoimmune skin disorders on post-operative outcomes following arthroplasty. Surgeon 2023; 21 (05) e292-e300
    CrossrefPubMedSearch in Google Scholar
  • 35 Raziyeva K, Kim Y, Zharkinbekov Z, Kassymbek K, Jimi S, Saparov A. Immunology of acute and chronic wound healing. Biomolecules 2021; 11 (05) 700
    CrossrefPubMedSearch in Google Scholar
  • 36 Linsenmayer TF, Hendrix MJ. Monoclonal antibodies to connective tissue macromolecules: type II collagen. Biochem Biophys Res Commun 1980; 92 (02) 440-446
    CrossrefPubMedSearch in Google Scholar
  • 37 Xiong L, Gazyakan E, Kremer T. et al. Free flaps for reconstruction of soft tissue defects in lower extremity: a meta-analysis on microsurgical outcome and safety. Microsurgery 2016; 36 (06) 511-524
    CrossrefPubMedSearch in Google Scholar
  • 38 Chen AD, Chi D, Wu WW. et al. The influence of connective tissue disease in breast reconstruction: a national database analysis. Ann Plast Surg 2018; 80 (4, Suppl 4): S182-S188
    CrossrefPubMedSearch in Google Scholar
  • 39 Adcock IM, Ito K. Molecular mechanisms of corticosteroid actions. Monaldi Arch Chest Dis 2000; 55 (03) 256-266
    PubMedSearch in Google Scholar
  • 40 Tian H, Cronstein BN. Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis. Bull NYU Hosp Jt Dis 2007; 65 (03) 168-173
    PubMedSearch in Google Scholar
  • 41 Allison AC. Mechanisms of action of mycophenolate mofetil. Lupus 2005; 14 (Suppl. 01) s2-s8
    CrossrefPubMedSearch in Google Scholar
  • 42 Mohammadi O, Kassim TA. Azathioprine. In: StatPearls. Treasure Island, FL: StatPearls Publishing; ; May 1, 2023
  • 43 Sbitany H, Xu X, Hansen SL, Young DM, Hoffman WY. The effects of immunosuppressive medications on outcomes in microvascular free tissue transfer. Plast Reconstr Surg 2014; 133 (04) 552e-558e
    CrossrefPubMedSearch in Google Scholar
  • 44 Wang AS, Armstrong EJ, Armstrong AW. Corticosteroids and wound healing: clinical considerations in the perioperative period. Am J Surg 2013; 206 (03) 410-417
    CrossrefPubMedSearch in Google Scholar
  • 45 Wicke C, Halliday B, Allen D. et al. Effects of steroids and retinoids on wound healing. Arch Surg 2000; 135 (11) 1265-1270
    CrossrefPubMedSearch in Google Scholar
  • 46 Anstead GM. Steroids, retinoids, and wound healing. Adv Wound Care 1998; 11 (06) 277-285
    PubMedSearch in Google Scholar
  • 47 Yang S, Zhang L. Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol 2004; 2 (01) 1-12
    CrossrefPubMedSearch in Google Scholar
  • 48 Goh L, Jewell T, Laversuch C, Samanta A. Should anti-TNF therapy be discontinued in rheumatoid arthritis patients undergoing elective orthopaedic surgery? A systematic review of the evidence. Rheumatol Int 2012; 32 (01) 5-13
    CrossrefPubMedSearch in Google Scholar
  • 49 Loza E, Martinez-Lopez JA, Carmona L. A systematic review on the optimum management of the use of methotrexate in rheumatoid arthritis patients in the perioperative period to minimize perioperative morbidity and maintain disease control. Clin Exp Rheumatol 2009; 27 (05) 856-862
    PubMedSearch in Google Scholar
  • 50 Wong M, Ziring D, Korin Y. et al. TNFalpha blockade in human diseases: mechanisms and future directions. Clin Immunol 2008; 126 (02) 121-136
    CrossrefPubMedSearch in Google Scholar
  • 51 Ehrlich HP, Hunt TK. Effects of cortisone and vitamin A on wound healing. Ann Surg 1968; 167 (03) 324-328
    CrossrefPubMedSearch in Google Scholar
  • 52 Hunt TK. Vitamin A and wound healing. J Am Acad Dermatol 1986; 15 (4, Pt 2): 817-821
    CrossrefPubMedSearch in Google Scholar